Investigative Clinical Research of Indiana — Indianapolis, Indiana

Investigative Clinical Research of Indiana is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Investigative Clinical Research of Indiana has participated in 15 clinical trials with 1 currently active.

Therapeutic areas: Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Sponsors: CTI BioPharma, BioVex Limited, Helsinn Therapeutics (U.S.), Inc.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Clinical Research of Indiana?

Investigative Clinical Research of Indiana has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Clinical Research of Indiana conducted?

Investigative Clinical Research of Indiana has 15 clinical trials on record, with 1 currently active. Their work covers Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Is Investigative Clinical Research of Indiana accredited by Crixeo Health?

Yes — Investigative Clinical Research of Indiana holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Investigative Clinical Research of Indiana?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.